FLU‐LISA ( fluorescence‐linked immunosorbent assay ) : high‐throughput antibody profiling using antigen microarrays
Immunology & Cell Biology · 2023
DOI: 10.1111/imcb.12618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology & Cell Biology, 2023. Verfasst von Shlomia Levy und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Shraga Segal Department of Microbiology and Immunology, Ben-Gurion University of the Negev, Beer-Sheva, Israel. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Foundation for the National Institutes of Health, Israel Science Foundation.
Abstract (Originalsprache)
Vaccination and natural infection both elicit potent humoral responses that provide protection from subsequent infections. The immune history of an individual following such exposures is in part encoded by antibodies. While there are multiple immunoassays for measuring antibody responses, the majority of these methods measure responses to a single antigen. A commonly used method for measuring antibody responses is ELISA—a semiquantitative assay that is simple to perform in research and clinical settings. Here, we present FLU‐LISA (fluorescence‐linked immunosorbent assay)—a novel antigen microarray‐based assay for rapid high‐throughput antibody profiling. The assay can be used for profiling immunoglobulin (Ig) G, IgA and IgM responses to multiple antigens simultaneously, requiring minimal amounts of sample and antigens. Using several influenza and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antigen microarrays, we demonstrated the specificity and sensitivity of our novel assay and compared it with the traditional ELISA, using samples from mice, chickens and humans. We also showed that our assay can be readily used with dried blood spots, which can be collected from humans and wild birds. FLU‐LISA can be readily used to profile hundreds of samples against dozens of antigens in a single day, and therefore offers an attractive alternative to the traditional ELISA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Shraga Segal Department of Microbiology and Immunology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- National Institute of Biotechnology in the Negev, Beer-Sheva, Israel.
- Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
- Vaccine and Infectious Disease Division, Fred Hutch Cancer Research Center, Seattle, WA, USA.
ORCID-Profile: Maureen A McGargill, Tomer Hertz
Förderung
- NIAID NIH HHS
- Foundation for the National Institutes of Health
- Israel Science Foundation
Zitieren
APA
Levy, S., Abd Alhadi, M., Azulay, A., Kahana, A., Bujanover, N., Gazit, R., McGargill, M. A., Friedman, L. M., & Hertz, T. (2023). FLU‐LISA ( fluorescence‐linked immunosorbent assay ) : high‐throughput antibody profiling using antigen microarrays. Immunology & Cell Biology. https://doi.org/10.1111/imcb.12618
Vancouver
Levy S, Abd Alhadi M, Azulay A, Kahana A, Bujanover N, Gazit R, et al. FLU‐LISA ( fluorescence‐linked immunosorbent assay ) : high‐throughput antibody profiling using antigen microarrays. Immunology & Cell Biology. 2023. doi:10.1111/imcb.12618
BibTeX
@article{Levy2023,
author = {Levy, Shlomia and Abd Alhadi, Marwa and Azulay, Asaf and Kahana, Amit and Bujanover, Nir and Gazit, Roi and McGargill, Maureen A and Friedman, Lilach M and Hertz, Tomer},
title = {FLU‐LISA ( fluorescence‐linked immunosorbent assay ) : high‐throughput antibody profiling using antigen microarrays},
journal = {Immunology & Cell Biology},
year = {2023},
doi = {10.1111/imcb.12618}
}
EUVIMED